Navigation Links
BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
Date:12/7/2010

NOVATO, Calif., Dec. 7, 2010 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Joshua Grass, Vice President of Corporate and Business Development of BioMarin, will present a company update at the Deutsche Bank 2010 BioFEST Conference in Boston on Tuesday, December 14, 2010 at 9:00 a.m. ET.  

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
2. BioMarin Announces Third Quarter 2010 Financial Results
3. BioMarin to Host a Research and Development Day on October 19th
4. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
5. BioMarin to Present at the UBS Global Life Sciences Conference
6. BioMarin to Present at the Stifel Nicolaus Healthcare Conference
7. BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
8. BioMarin Acquires ZyStor Therapeutics, Inc.
9. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... financial results for the third quarter fiscal year ... has scheduled a conference call that same day, ...
(Date:4/30/2015)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... financial results for the fourth quarter and fiscal year ... fiscal 2015 overview: , Revenues from continuing operations ... over last year,s comparable quarter, and $202.6 million for ... of $0.50 for the fourth quarter, up 194% over ...
(Date:4/30/2015)... 30, 2015  Thoratec Corporation (NASDAQ: THOR ), ... save, support and restore failing hearts, said today it ... 2015 Healthcare Conference on Thursday, May 14. ... Officer, will provide an update on the company, beginning ... Daylight Time). The presentation will be available ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2
... Dec. 20, 2011 With the year end fast ... (PTCB) Certified Pharmacy Technicians (CPhTs), continue to provide patients ... 2011 Flexible Spending Account (FSA) funds. ... 35 million families in the United States to set ...
... Dec. 20, 2011 Reportlinker.com announces that a ... catalogue: , Orphan Drug Markets in Europe ... Key developments and the strategies of ... introduction of orphan products in Europe remains problematic ...
Cached Medicine Technology:Retail Pharmacy Teams Help Patients Maximize FSA Funds Before Year End 2Orphan Drug Markets in Europe 2Orphan Drug Markets in Europe 3Orphan Drug Markets in Europe 4Orphan Drug Markets in Europe 5Orphan Drug Markets in Europe 6Orphan Drug Markets in Europe 7
(Date:5/4/2015)... Los Angeles, CA (PRWEB) May 04, 2015 ... Marcia Hinds, Eric Gladen’s documentary Trace Amounts, and Allison ... comprehensive annual autism conference held internationally. , On Sunday, ... There: Is recovery from autism possible?" Are you interested ... Know You’re In There: winning our war against autism ...
(Date:5/4/2015)... California (PRWEB) May 04, 2015 Sara ... a physician practice management firm in Los Angeles associated ... today the patent-pending status of The Sara Soulati Health ... Soulati in 2010, is a lifestyle modification and disease ... April 2015 to the U. S. Patents and Trademarks ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Leading international ... announced it will be awarding the 2015 Harris Wofford ... and Selemawit Ghebrendrias, are the deserving recipients of the ... global service, Harris Llewellyn Wofford. The two recipients were ... passion for global health. , CFHI is one ...
(Date:5/3/2015)... NuevaCare announced today that it will present ... The first event will take place on Wednesday, May ... be held at The Magnolia of Millbrae. The second ... the Dementia Conference to be held at the Foster ... excellent opportunity to learn about the MnemeTherapy® approach and ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 Ticket Down has ... for the long awaited event today, Saturday, May 2nd ... Diehard boxing fans will be able to secure tickets for ... The fight that boxing fans have wanted for more than ... ago. Floyd “Money” Mayweather will step inside the ring to ...
Breaking Medicine News(10 mins):Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... , Jan. 14 Thirteen Detroit -area residents ... and Human Services, Office of the Inspector General (HHS-OIG) and FBI ... the Medicare program of more than $14.5 million , announced ... Division; U.S. Attorney Barbara L. McQuade of the Eastern ...
... , MINNEAPOLIS and ST. ... Clinics of Minnesota is launching a major new initiative ... and St. Paul Hospitals.  This Arts and Healing initiative will ... a healing environment for patients and families at Children,s.  The program ...
... Cancer Research and the International Association for the Study of ... his leadership in lung cancer research at the first Molecular ... from Jan. 11-14, 2010, drew more than 300 people from ... James Dudley chair in cancer research at the University of ...
... 6 percent say they intended to cause harm, survey finds , ... that almost 27 percent of girls aged 12 to 17 were ... previous year. , "These findings are alarming," SAMHSA administrator Pamela ... a better job reaching girls at risk and teaching them how ...
... ... is pleased to announce the grand opening of its new retail site, CoastToCoastMattress.com. CoastToCoastMattress.com ... delivery for all orders within the continental United States. , ... (PRWEB) January 14, 2010 -- Coast To ...
... , ABBOTT PARK, Ill., Jan. 14 A new ... of whether a pelvic mass is benign or malignant, is now ... to help in the assessment of epithelial ovarian cancer, the most ... on Abbott,s ARCHITECT systems, is the first automated HE4 ...
Cached Medicine News:Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 2Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 3Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 4Health News:Children's Hospitals and Clinics of Minnesota Calls on Local Artists for New Arts and Healing Initiative 2Health News:Children's Hospitals and Clinics of Minnesota Calls on Local Artists for New Arts and Healing Initiative 3Health News:Lung cancer conference leaders honor Paul A. Bunn Jr., M.D. 2Health News:Coast To Coast Mattress Announces the Grand Opening of CoastToCoastMattress.com 2Health News:Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: